Carysil Limited

BSE:524091 Rapport sur les actions

Capitalisation boursière : ₹32.7b

Carysil Croissance future

Future contrôle des critères 3/6

Carysil devrait augmenter ses bénéfices et son chiffre d'affaires de 17.4% et de 15.5% par an respectivement. Le BPA devrait croître de de 17.3% par an. Le rendement des capitaux propres devrait être 17.4% dans 3 ans.

Informations clés

17.4%

Taux de croissance des bénéfices

17.35%

Taux de croissance du BPA

Building croissance des bénéfices21.4%
Taux de croissance des recettes15.5%
Rendement futur des capitaux propres17.43%
Couverture par les analystes

Low

Dernière mise à jour22 May 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit • Jun 18

524091: Subsidiary Simplification And Dividend Plans Will Shape Future Share Performance

Analysts have kept their fair value estimate for Carysil steady at ₹1,270.50, with the small adjustments in discount rate, revenue growth, profit margin and future P/E assumptions leading to only a marginal refinement in the overall price target narrative. What’s in the News for Carysil Board meeting on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on equity shares for the financial year ended March 31, 2026.
Mise à jour du récit • Jun 02

524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside

Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.
Mise à jour du récit • May 17

524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside

Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).
Mise à jour du récit • Apr 28

524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside

Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.
Mise à jour du récit • Apr 12

524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside

Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Mise à jour du récit • Mar 28

524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside

Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.
Mise à jour du récit • Mar 11

524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside

Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Mise à jour du récit • Feb 25

524091: Upcoming Results And Steady Assumptions Will Support Future Upside

Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.
Mise à jour du récit • Feb 11

524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside

Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Mise à jour du récit • Jan 27

524091: Steady Outlook And Upcoming Results Date Will Support Future Upside

Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.
Mise à jour du récit • Jan 10

524091: Steady Assumptions And Upcoming Results Will Support Future Upside

Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.
Mise à jour du récit • Dec 15

524091: Capacity Expansion Will Drive Future Earnings Momentum

Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
Mise à jour du récit • Dec 01

524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum

Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).
Mise à jour du récit • Nov 16

524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook

Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).
Mise à jour du récit • Aug 18

Global Kitchen Upgrades And Market Expansion Will Transform Industry

Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
User avatar
Nouveau récit • Feb 18

Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions

Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.

Prévisions de croissance des bénéfices et des revenus

BSE:524091 - Estimations futures des analystes et données financières antérieures (INR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
3/31/202812,6611,3904911,2443
3/31/202711,1001,1504761,1481
3/31/20269,240982-281,087N/A
12/31/20258,944897N/AN/AN/A
9/30/20258,750811203817N/A
6/30/20258,414707N/AN/AN/A
3/31/20258,156637129602N/A
12/31/20248,019608N/AN/AN/A
9/30/20247,868635-1,289-452N/A
6/30/20247,433622N/AN/AN/A
3/31/20246,838579-397534N/A
12/31/20236,388548N/AN/AN/A
9/30/20235,886515207812N/A
6/30/20235,642453N/AN/AN/A
3/31/20235,939524133712N/A
12/31/20225,872564N/AN/AN/A
9/30/20225,77561628737N/A
6/30/20225,577700N/AN/AN/A
3/31/20224,839648-256516N/A
12/31/20214,456614N/AN/AN/A
9/30/20214,05156344659N/A
6/30/20213,613480N/AN/AN/A
3/31/20213,09739189454N/A
12/31/20202,734300N/AN/AN/A
9/30/20202,591247243402N/A
6/30/20202,542209N/AN/AN/A
3/31/20202,762221102301N/A
12/31/20192,772223N/AN/AN/A
9/30/20192,662186N/A286N/A
6/30/20192,594187N/AN/AN/A
3/31/20192,516172N/A237N/A
12/31/20182,370155N/AN/AN/A
9/30/20182,226143N/AN/AN/A
6/30/20182,128126N/AN/AN/A
3/31/20181,965120N/A156N/A
12/31/20171,877117N/AN/AN/A
9/30/20171,806106N/AN/AN/A
6/30/20171,79299N/AN/AN/A
3/31/20171,81073N/A57N/A
12/31/20161,89490N/AN/AN/A
9/30/20161,907101N/AN/AN/A
6/30/20161,79694N/AN/AN/A
3/31/20161,738109N/A106N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 524091 ( 17.4% par an) est supérieure au taux d'épargne ( 6.9% ).

Bénéfices vs marché: Les bénéfices de 524091 ( 17.4% par an) devraient croître plus rapidement que le marché Indian ( 16.1% par an).

Croissance élevée des bénéfices: Les bénéfices de 524091 devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 524091 ( 15.5% par an) devrait croître plus rapidement que le marché Indian ( 11% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 524091 ( 15.5% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de 524091 devrait être faible dans 3 ans ( 17.4 %).

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/07/28 06:00
Cours de l'action en fin de journée2026/07/28 00:00
Les revenus2026/03/31
Revenus annuels2026/03/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Carysil Limited est couverte par 7 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Rishab BothraAnand Rathi Shares and Stock Brokers Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Vyom ChhedaBP Wealth Management Private Limited